Taysha Gene Therapies Competitors and Similar CompaniesClear all

Taysha Gene Therapies's competitors and similar companies include Voyager Therapeutics, Lacerta Therapeutics and Passage Bio.
Taysha Gene Therapies
Taysha Gene Therapies
Taysha Gene Therapies is a biotechnology company that develops therapies.
Voyager Therapeutics
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for diseases of the central nervous system (CNS).
Lacerta Therapeutics
Lacerta Therapeutics
Lacerta Therapeutics is a clinical stage gene therapy company.
Passage Bio
Passage Bio
Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases.
Founding Date
Founding Date
2020
Founding Date
2014
Founding Date
2017
Founding Date
2018
Type
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Dallas, US HQ
Locations
Cambridge, US HQ
Locations
Alachua, US HQ
Alachua, US
Locations
Philadelphia, US HQ
Employees
Employees
5220% decrease
Employees
16230% increase
Employees
13
Employees
20
Valuation ($)
Valuation ($)
385.3 m
Valuation ($)
382.8 m
Valuation ($)
N/A
Valuation ($)
39.4 m

Financial

Revenue (est.)
Revenue (est.)
$9.8m (FY, 2025)
Revenue (est.)
$40.4m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($109m) (FY, 2025)
Net income
($119.7m) (FY, 2025)
Net income
N/A
Net income
($45.5m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 125m
Total funding raised
$ 135m
Total funding raised
$ 30m
Total funding raised
$ 225.5m
For sources of this data, please see the company profile

View Company Profiles

Voyager Therapeutics
HQ
Cambridge, US
Employees
162↑ 30% increase

Voyager Therapeutics is a gene therapy company developing treatments for diseases of the central nervous system (CNS).

View company
Lacerta Therapeutics
HQ
Alachua, US
Employees
13

Lacerta Therapeutics is a clinical stage gene therapy company.

View company
Passage Bio
HQ
Philadelphia, US
Employees
20

Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases.

View company